News
Thermo Fisher Scientific Officially Opens New Site for Manufacturing COVID-19 Sample Collection Products
Thermo Fisher Scientific Inc., the world leader in serving science, officially cut the ribbon on its new $40 million facility in Lenexa, Kansas dedicated to viral transport media (VTM) production. The company is also announcing that the site will...
News
CSafe Global Expands Further into Asia Opening Hub Operations in Taipei, Taiwan
CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, has once again expanded their global reach and local presence with the opening of a new hub operation in Taipei, Taiwan.
This new addition to...
News
Stevanato Group signs an agreement with Nelson Labs to provide best-in-class Extractables & Leachables testing services at its US Technology Excellence Center
Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated services for combination products, and Nelson Laboratories, LLC, a global provider of lab testing and expert advisory services signed a partnership agreement that will provide...
News
EU approves AstraZeneca’s Imfinzi for treatment of extensive-stage small cell lung cancer
AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union for the first-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) in combination with a choice of chemotherapies, etoposide plus either carboplatin or cisplatin.
SCLC is a highly...
News
AstraZeneca begins Phase III trial of Covid-19 vaccine in US
AstraZeneca has expanded the clinical development of its potential Covid-19 vaccine candidate AZD1222 in the US, by initiating a Phase 3 clinical trial, dubbed D8110C00001.
The late-stage clinical trial is aimed at evaluating the safety, efficacy and immunogenicity of the...
News
Sanofi provides update on Kevzara Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.
Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara® (sarilumab) at a dose of 200 mg or 400 mga in severely or critically illb patients hospitalized with COVID-19 did not meet its primary endpoint and key...
Drug Research
Piramal Pharma to Collaboratewith Epirium Bio on Exclusive Integrated Development & Manufacturing Program for Orphan Drugs
Piramal Pharma Solutions, a leading contract development and manufacturing organization (CDMO), today announced that the company will be partnering with Epirum Bio on an exclusivemanufacturing relationship fornew orphan drugs targeting rare diseases with high unmetneeds.
The Piramal Pharma Solutions (PPS)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.